The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant pazopanib with radiation therapy in patients with localized sarcoma: Experience from a sarcoma center.
 
Marcus Trybula
No Relationships to Disclose
 
Ankit Mangla
Consulting or Advisory Role - SpringWorks Therapeutics
Research Funding - BioAtla; Boehringer Ingelheim; Dragonfly Therapeutics; Pfizer; Regeneron; SpringWorks Therapeutics; TRACON Pharma
 
Luke Daniel Rothermel
No Relationships to Disclose
 
Brandon Jonard
No Relationships to Disclose
 
Raed Zuhour
No Relationships to Disclose
 
Alessandra Nascimento
No Relationships to Disclose
 
Shahrazad Saab
No Relationships to Disclose
 
Salim Abboud
No Relationships to Disclose
 
David B. Mansur
No Relationships to Disclose
 
John Brian Ammori
No Relationships to Disclose
 
Monique Wolf
No Relationships to Disclose
 
Jessica Sidiropoulos
No Relationships to Disclose
 
Taylor M. Costello
No Relationships to Disclose
 
Pingfu Fu
No Relationships to Disclose
 
Gary K. Schwartz
Stock and Other Ownership Interests - Bionaut Labs; GenCirq; January Therapeutics
Consulting or Advisory Role - AADi; Agenus; Astex Pharmaceuticals; Bionaut Labs; Boehringer Ingelheim; Concarlo; Gencirq; Ipsen; January Therapeutics; Kirilys Therapeutics; Oncogenuity; OnCusp Therapeutics; PureTech; Shanghai Pharma
Research Funding - Astex Pharmaceuticals; Oxford BioTherapeutics (Inst); PTC Therapeutics (Inst); Rain Therapeutics (Inst); SpringWorks Therapeutics (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Companion diagnostics for CD4 inhibitors (Inst); patent granted to develop a new technology called PNAs for cancer therapy
Travel, Accommodations, Expenses - Boehringer Ingelheim